Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Prim Prev ; 35(2): 93-102, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24259082

ABSTRACT

Street-based sex-work and poly-substance drug use, coupled with low vaccination rates and limited utilization of the mainstream health care system, put the sex worker communities of Bogotá's city center at extreme risk of infection with the hepatitis B virus (HBV). Vaccination is critical to maintaining low prevalence of the disease and low incidence of new cases, yet the floating and inconsistent nature of Bogotá's drug-involved female and transsexual prostitution communities make it difficult to complete a 3-dose vaccination program. Between December 2011 and March of 2012, the Fénix Foundation collaborated with the Bogotá Health Department to deliver free HBV vaccines to this vulnerable population. This paper outlines methods used in the vaccination program to generate a 37.7% adherence rate, significantly higher than that previously reported for HBV vaccination programs also targeting marginalized populations. This program's practices are based on the Fénix peer leader method, and are offered as a model that can be applied to other health interventions operating in analogous contexts, with similarly high-risk populations.


Subject(s)
Health Services Accessibility/organization & administration , Hepatitis B Vaccines , Medication Adherence/psychology , Sex Work/psychology , Substance-Related Disorders/psychology , Vaccination , Adult , Colombia , Female , Health Promotion/organization & administration , Humans , Male , Urban Population , Vulnerable Populations/psychology
3.
J Int Assoc Provid AIDS Care ; 14(2): 103-7, 2015.
Article in English | MEDLINE | ID: mdl-25331226

ABSTRACT

In 2012, the US Food and Drug Administration approved Truvada as a pre-exposure prophylaxis (PrEP) for adults at risk of HIV. PrEP is highly effective at preventing HIV when taken daily, but no gold standard exists for consistently administering PrEP to populations at highest risk. The "I Am Men's Health" program used an innovative methodology to generate adherence to PrEP in 23 mostly young men who have sex with men of color (yMSMc), during a 28-week period from February to September 2013. Adherence was measured using weekly medication pickup rates. The average age of the participants was 21 years, and the majority were black and lived below the poverty line. Time on PrEP ranged from 1 to 28 weeks (2723 person-days), and the weighted average adherence was 73%. The methodology used in this study was preliminarily effective at generating adherence to PrEP among high-risk yMSMc in a community setting and may help inform large-scale future HIV prevention interventions.


Subject(s)
Anti-HIV Agents/administration & dosage , Deoxycytidine/analogs & derivatives , HIV Infections/prevention & control , HIV Infections/psychology , Homosexuality, Male/psychology , Medication Adherence , Organophosphorus Compounds/administration & dosage , Adult , Black People/psychology , Deoxycytidine/administration & dosage , Drug Combinations , Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination , Female , HIV Infections/drug therapy , Humans , Male , Pre-Exposure Prophylaxis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL